ストックスクリーナーアプリを入手
17.77
4.56%
0.7749
アフターアワーズ：
17.78
0.005
+0.03%
前日終値:
$17.00
開ける：
$17.57
24時間の取引高:
3,007
Relative Volume:
0.73
時価総額：
$429.59M
収益：
$1.70M
当期純損益:
$-47.01M
株価収益率:
-10.46
EPS:
-1.7
ネットキャッシュフロー:
$-157.28M
1週間 パフォーマンス:
+0.20%
1か月 パフォーマンス:
-3.92%
6か月 パフォーマンス:
+2.98%
1年 パフォーマンス:
-12.65%
1日の値動き範囲:
$17.49
$17.85
1週間の範囲:
$17.00
$17.85
52週間の値動き範囲:
$13.30
$24.99
Puretech Health Plc Adr Stock (PRTC) Company Profile
PRTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRTC
Puretech Health Plc Adr
|
17.77 | 410.87M | 1.70M | -47.01M | -157.28M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 398.11M | -1.03B | -868.57M | -5.7032 |
Puretech Health Plc Adr Stock (PRTC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-09-09 | 再開されました | Leerink Partners | Outperform |
Puretech Health Plc Adr (PRTC) 最新ニュース
PureTech Health PLC Sponsored ADR $PRTC Shares Sold by Birch Hill Investment Advisors LLC - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 100.0% in September - MarketBeat
Free cash flow per share of PureTech Health PLC Sponsored ADR – NASDAQ:PRTC - TradingView
PureTech Health (NASDAQ:PRTC) Trading Up 3.6%Here's What Happened - MarketBeat
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Significant Growth in Short Interest - MarketBeat
PureTech Health (LON:PRTC) Shares Up 14.2% – Should You Buy? - Defense World
PureTech Health (LON:PRTC) Trading 14.2% Higher – What’s Next? - Defense World
Parallel Advisors LLC Acquires 1,718 Shares of GSK PLC Sponsored ADR $GSK - Defense World
What Makes PureTech Health (PRTC) a New Buy Stock - Yahoo Finance
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Sees Large Growth in Short Interest - MarketBeat
PureTech Health (NASDAQ:PRTC) Shares Up 4.7%Time to Buy? - MarketBeat
PureTech Health Cash Runway Extended - The Motley Fool
International Flavors & Fragrances (NYSE:IFF) & DAQO New Energy (NYSE:DQ) Critical Comparison - Defense World
Conference Calls and Individual Investors - MarketBeat
Deupirfenidone: A Potential New Standard of Care - Placera.se
PureTech launches new entity to advance IPF treatment deupirfenidone - Investing.com
PureTech Health to report half-yearly results on August 28 - Investing.com
PureTech Health to report half-yearly results on August 28 By Investing.com - Investing.com South Africa
PureTech Health (NASDAQ:PRTC) Trading Up 1.4% – Still a Buy? - Defense World
PureTech Health (NASDAQ:PRTC) Shares Down 7.3% – Here’s What Happened - Defense World
PureTech’s Seaport doses first patient in phase 2b depression study By Investing.com - Investing.com South Africa
PureTech Health names Robert Lyne as interim CEO as Chowrira departs - Investing.com
PureTech Health names Robert Lyne as interim CEO as Chowrira departs By Investing.com - Investing.com India
Big Oil's Q2 Outlook: Downstream Gains and Upstream Pains - The Globe and Mail
PureTech Health announces board leadership transition By Investing.com - Investing.com South Africa
PureTech Health announces board leadership transition - Investing.com
PureTech Health announces board chair Raju Kucherlapati steps down - Investing.com
PureTech Health issues shares to executives following RSU vesting - Investing.com
PureTech Health announces RSU vesting and share transactions by PDMR - Investing.com
PureTech set for Jefferies Global Healthcare Conference chat By Investing.com - Investing.com India
PureTech set for Jefferies Global Healthcare Conference chat - Investing.com
PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial - Placera.se
PureTech research reveals gaps in IPF patient care - Investing.com
PureTech research reveals gaps in IPF patient care By Investing.com - Investing.com South Africa
PureTech Health PLC (PTCHF) (FY 2024) Earnings Call Highlights: Strong Financial Execution and ... By GuruFocus - Investing.com Canada
PureTech Health to release annual financial results April 30 - Investing.com
PureTech Health to release annual financial results April 30 By Investing.com - Investing.com India
PureTech Health enlists Peel Hunt as joint broker - Investing.com
Invesco Ltd: Form 8.3PureTech Health PLC; Opening Position disclosure - The Manila Times
Nordic Capital XI ends pursuit of PureTech acquisition - Investing.com
India Peanut Allergy Treatment Market Size & Outlook, 2030 - Grand View Research
Top Biotech Stocks: Exploring Innovation Opportunities - MarketBeat
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share - FinancialContent
symbol__ Stock Quote Price and Forecast - CNN
The definitive Boston biotech layoff tracker for 2023 - The Business Journals
Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time - MarketBeat
This Emerging Market Could Be The Next Big Thing In Biotech - Barchart.com
PureTech Share Price (PRTC) - London South East
Royalty Pharma and PureTech Health Enter KarXT Royalty Agreement for Up to $500M - Investing.com India
What is the current Price Target and Forecast for PureTech Health (PRTC) - Zacks Investment Research
The Petri Dish: 1910 Genetics hires CBO; PureTech calls off merger - The Business Journals
Puretech Health Plc Adr (PRTC) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):